Last reviewed · How we verify
contrast agent, Gadolinium — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
contrast agent, Gadolinium (contrast agent, Gadolinium) — Hôpital Fribourgeois.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| contrast agent, Gadolinium TARGET | contrast agent, Gadolinium | Hôpital Fribourgeois | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- contrast agent, Gadolinium CI watch — RSS
- contrast agent, Gadolinium CI watch — Atom
- contrast agent, Gadolinium CI watch — JSON
- contrast agent, Gadolinium alone — RSS
Cite this brief
Drug Landscape (2026). contrast agent, Gadolinium — Competitive Intelligence Brief. https://druglandscape.com/ci/contrast-agent-gadolinium. Accessed 2026-05-15.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab